Skip to content
  • ABOUT US
    • What Do We Do?
    • Why Are We Better?
    • Senior Management
    • How To Contact Us
  • TRANSACTIONS
    • Chemical Transactions
    • Life Science Transactions
  • BROADCASTS & PUBLICATIONS
    • Our Broadcasts
    • Our Publications
    • Our Analyses
      • Chemical Industry Analyses
      • Pharmaceutical Industry Analyses
      • Biotechnology Industry Analyses
      • Medical Device Industry Analyses
  • CONFERENCES
    • Chemical Conferences
    • Life Science Conferences
  • INDUSTRY PORTALS
    • ChemicalIndustry.com
    • PharmaIndustry.com
    • MedicalDeviceIndustry.com
  • YOUNG & PARTNERS FORUM
  • ABOUT US
    • What Do We Do?
    • Why Are We Better?
    • Senior Management
    • How To Contact Us
  • TRANSACTIONS
    • Chemical Transactions
    • Life Science Transactions
  • BROADCASTS & PUBLICATIONS
    • Our Broadcasts
    • Our Publications
    • Our Analyses
      • Chemical Industry Analyses
      • Pharmaceutical Industry Analyses
      • Biotechnology Industry Analyses
      • Medical Device Industry Analyses
  • CONFERENCES
    • Chemical Conferences
    • Life Science Conferences
  • INDUSTRY PORTALS
    • ChemicalIndustry.com
    • PharmaIndustry.com
    • MedicalDeviceIndustry.com
  • YOUNG & PARTNERS FORUM

Our Publications

  • Our Broadcasts
  • Our Publications
  • Our Analyses
Jonathan Choi2025-02-05T22:13:34+00:00

Reflections on 2024 and Outlook – Stock Market and Funding

Young & Partners shares proprietary analysis of the stock market and funding environment in Biotech and Pharma and the outlook for 2025.

Jonathan Choi2025-02-05T22:09:34+00:00

Reflections on 2024 and Outlook – Senior Management Approach to M&A

Young & Partners shares proprietary analysis and outlook of how managers and executive should approach Biotech and Pharma M&A market in 2025.

Jonathan Choi2025-02-05T22:03:00+00:00

Reflections on 2024 and Outlook – Biotech and Pharma M&A

Young & Partners shares proprietary analysis of the global disruptions and uncertainties that have affected the Biotech and Pharma M&A market in 2024 and the outlook for 2025.

Jonathan Choi2024-11-06T21:10:32+00:00

Young & Partners Pharmaceutical Executive Summit 2024: The Impact of Artificial Intelligence on the Creation of Medicines (Pharmaceutical Executive)

Pharmaceutical Executive shares Fred Hassan's and Najat Khan's comments made at the 2024 Young & Partners Pharmaceutical Executive Summit. https://www.pharmexec.com/view/young-partners-pharmaceutical-executive-summit-2024-impact-artificial-intelligence-creation-medicines

Jonathan Choi2024-11-06T21:10:53+00:00

Young & Partners Pharmaceutical Executive Summit 2024: Brave New World – Where Are We Heading? (Pharmaceutical Executive)

Pharmaceutical Executive shares Peter Marks' comments made at the 2024 Young & Partners Pharmaceutical Executive Summit. https://www.pharmexec.com/view/young-partners-pharmaceutical-executive-summit-2024-brave-new-world-where-heading-

Jonathan Choi2024-10-14T18:41:13+00:00

Industry Restructuring & Inorganic Growth Through an Era of Chronic Oversupply (World Chemical Forum Speech September 10, 2024)

Young & Partners shares their thoughts and analysis of the global oversupply and uncertainties that have impacted the chemical markets. The presentation addresses the era of chronic oversupply, strategic assessments, M&A market conditions, and Strategic and M&A alternatives.

Jonathan Choi2024-10-15T15:22:50+00:00

Chemical Debt Financing Rebounds (ICIS Chemical Business September 6 – September 12, 2024)

Young & Partners shares proprietary analysis of the global disruptions and uncertainties that have rebounded chemical debt financings and the outlook for 2024.

Jonathan Choi2024-09-17T14:15:04+00:00

Chemical M&A Retreats Further (ICIS Chemical Business August 31 – September 5, 2024)

Young & Partners shares proprietary analysis of the global disruptions and uncertainties that have suppressed chemical M&A and the outlook for 2024.

Jonathan Choi2024-06-20T16:34:06+00:00

Chemical Financing Activity Mixed (ICIS Chemical Business May 31 – June 6, 2024)

Young & Partners shares proprietary analysis of the global disruptions and uncertainties that have suppressed chemical financing and the outlook for 2024.

Jonathan Choi2024-05-22T20:35:28+00:00

Chemical M&A Market Retreats (ICIS Chemical Business May 17 – May 23, 2024)

Young & Partners shares proprietary analysis of the global disruptions and uncertainties that have suppressed M&A and the outlook for 2024.

Previous123Next

DISCLAIMER

JOIN OUR MAILING LIST

© YOUNG & PARTNERS LLC   |   535 Fifth Avenue, 4th Floor, New York, New York 10017 | 212-682-5555

Page load link
Go to Top